Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association Study between Mucin 4 (MUC4) Polymorphisms and Idiopathic Recurrent Pregnancy Loss in a Korean Population. | Genes (Basel) | 2022 | 35741699 | PubTator, text mining | PubMed |
| Practical Approach to Histological Diagnosis of Peripheral Nerve Sheath Tumors: An Update. | Diagnostics (Basel) | 2022 | 35741273 | PubTator, text mining | PubMed |
| Management of Pancreatic Cancer and Its Microenvironment: Potential Impact of Nano-Targeting. | Cancers (Basel) | 2022 | 35740545 | PubTator, text mining | PubMed |
| A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes. | BMC Cancer | 2022 | 35739510 | PubTator, text mining | PubMed |
| Application of Artificial Intelligence in the Management of Pancreatic Cystic Lesions. | Biomimetics (Basel) | 2022 | 35735595 | PubTator, text mining | PubMed |
| Rare Variants in Novel Candidate Genes Associated With Nonsyndromic Patent Ductus Arteriosus Identified With Whole-Exome Sequencing. | Front Genet | 2022 | 35734438 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development. | Front Genet | 2022 | 35734437 | PubTator, text mining | PubMed |
| Cyanidin-3-Glucoside Modulates hsa_circ_0001345/miRNA106b/ATG16L1 Axis Expression as a Potential Protective Mechanism against Hepatocellular Carcinoma. | Curr Issues Mol Biol | 2022 | 35723373 | PubTator, text mining | PubMed |
| Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma. | Ann Transl Med | 2022 | 35722420 | PubTator, text mining | PubMed |
| CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer. | Cell Mol Biol Lett | 2022 | 35715750 | PubTator, text mining | PubMed |
| Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applications. | Am J Surg | 2022 | 35715267 | PubTator, text mining | PubMed |
| Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for Thought. | Front Immunol | 2022 | 35711414 | PubTator, text mining | PubMed |
| Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis. | PLoS One | 2022 | 35709153 | PubTator, text mining | PubMed |
Gene Differential Expression and Interaction Networks Illustrate the Biomarkers and Molecular Biological Mechanisms of Unsaponifiable Matter in Kanglaite Injection for Pancreatic Ductal Adenocarcinoma. | Biomed Res Int | 2022 | 35707377 | PubTator, text mining | PubMed |
| Breast Cancer Prognosis Prediction and Immune Pathway Molecular Analysis Based on Mitochondria-Related Genes. | Genet Res (Camb) | 2022 | 35707265 | PubTator, text mining | PubMed |
| Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients. | Int J Gen Med | 2022 | 35702368 | PubTator, text mining | PubMed |
| A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc. | Am J Transl Res | 2022 | 35702130 | PubTator, text mining | PubMed |
| Membrane-Tethered Mucin 1 Is Stimulated by Interferon and Virus Infection in Multiple Cell Types and Inhibits Influenza A Virus Infection in Human Airway Epithelium. | mBio | 2022 | 35699372 | PubTator, text mining | PubMed |
| Mixed-type multivariate response regression with covariance estimation. | Stat Med | 2022 | 35699353 | PubTator, text mining | PubMed |
| Human-host transcriptomic analysis reveals unique early innate immune responses in different sub-phenotypes of COVID-19. | Clin Transl Med | 2022 | 35696527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=50